Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tectonic TherapeuticTECX -7.84%14 1-Year ROIIC % is -1,377.80 as of Jun. 2026. GuruFocus rates TECX with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 1,325 Biotechnology companies, Tectonic Therapeutic ranks worse than 94.11% on this metric.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
Tectonic Therapeutic's 1-Year ROIIC % for the quarter that ended in Jun. 2026 was -1,377.80%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Tectonic Therapeutic's 1-Year ROIIC % or its related term are showing as below:
TECX's 1-Year ROIIC % is ranked worse than 94.11% of 1325
companies
in the Biotechnology industry
Industry Median: -8.61
vs TECX: -1377.80
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Tectonic Therapeutic 1-Year ROIIC % Related Terms
Tectonic Therapeutic 1-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Tectonic Therapeutic's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TECX vs ZVRA, SPRY, RLMD: 1-Year ROIIC % Comparison
For the Biotechnology subindustry, Tectonic Therapeutic's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tectonic Therapeutic 1-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tectonic Therapeutic's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Tectonic Therapeutic's 1-Year ROIIC % falls into.
Tectonic Therapeutic's 1-Year ROIIC % for the quarter that ended in Jun. 2026 is calculated as:
1-Year ROIIC %
=
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( -94.925 (Jun. 2026) - -74.258 (Jun. 2025) )
/
( 10.086 (Jun. 2026) - 8.586 (Jun. 2025) )
=
-20.667
/
1.5
=
-1,377.80%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Tectonic Therapeutic (TECX) has a 1-Year ROIIC % of -1,377.80 as of Jun. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Tectonic Therapeutic and its competitors. According to the industry distribution chart, Tectonic Therapeutic ranks #1247 out of 1325 companies in the Biotechnology industry, placing it in the top 94.1%.
Is Tectonic Therapeutic's 1-Year ROIIC % too high?
Tectonic Therapeutic's current 1-Year ROIIC % is -1,377.80. Based on the distribution chart, Tectonic Therapeutic ranks #1247 out of 1325 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tectonic Therapeutic has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tectonic Therapeutic's 1-Year ROIIC % compare to ZVRA and SPRY?
According to the Biotechnology industry distribution chart, Tectonic Therapeutic ranks #1247 out of 1325 companies for 1-Year ROIIC %. This places Tectonic Therapeutic in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Biotechnology company?
A good 1-Year ROIIC % depends on the Biotechnology industry context. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Tectonic Therapeutic and its competitors. Tectonic Therapeutic's current 1-Year ROIIC % is -1,377.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tectonic Therapeutic stock overvalued right now?
Tectonic Therapeutic (TECX) has a current 1-Year ROIIC % of -1,377.80. The current 1-Year ROIIC % is -1,377.80. Tectonic Therapeutic's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Tectonic Therapeutic (TECX), the current 1-Year ROIIC % is -1,377.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
14GF Score
Get the complete analysis for TECX
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TECX has been successfully added to your 
